Case Studies in Unresectable Hepatocellular Carcinoma

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal.

HCC Overview

General Approaches to Treatment

General Approaches to Treatment (cont)

Case 1

Case Discussion

Case 1 (cont)

RESORCE Trial

Phase 3 Trials in Second-Line Settings

REFLECT Trial

Absence of Correlation Between TTP and OS

Case 2

Case 2 (cont)

Nivolumab CheckMate 040 Trial

Panel Discussion

Conclusions

Abbreviations